$VKTX
-
Markets
Viking Therapeutics Demonstrates Resilience Amid Market Fluctuations
$VKTX Viking Therapeutics Inc. (NASDAQ:VKTX) has shown notable resilience in recent trading sessions, with significant movements in its stock price…
Read More » -
Markets
Viking Therapeutics, Inc. Experiences Notable Surge Amid Market Challenges
$VKTX On a recent Wednesday, Viking Therapeutics, Inc. (NASDAQ:VKTX) witnessed a significant surge in its stock price, closing at $32.29,…
Read More » -
Markets
Viking Therapeutics: Developments and Considerations in Biopharmaceutical Research
$VKTX Viking Therapeutics, Inc. (NASDAQ:VKTX) has recently garnered attention due to fluctuations in its stock performance and its efforts in…
Read More » -
Markets
Biotech Sector Faces Key Developments in Weight-Loss Drug Advancements
$VKTX As 2025 begins, the biotechnology sector is focused on significant advancements in weight-loss drugs, with Viking Therapeutics Inc. (NASDAQ:…
Read More » -
Markets
Viking Therapeutics Positioned for Growth Amidst Market Dynamics
$VKTX Viking Therapeutics (NASDAQ: VKTX) operates in the biopharmaceutical sector, with a focus on developing therapies for metabolic and endocrine…
Read More » -
Markets
Madrigal Pharmaceuticals Surges Following Competitor’s Disappointing Treatment Results
$VKTX Madrigal Pharmaceuticals saw a significant increase in its stock value on Friday, driven by disappointing results from competitor Novo…
Read More » -
Markets
Viking Therapeutics’ Weight-Loss Pill Trials Show Breakthrough Results, Exceeding Expectations
$VKTX In a significant advancement in obesity treatment, Viking Therapeutics (Nasdaq: VKTX ) has reported remarkable outcomes from its recent…
Read More » -
Markets
Viking Therapeutics: Pipeline Advancements and Competitive Market Position
$VKTX Viking Therapeutics (NASDAQ:VKTX) is preparing to release its Q3 earnings on October 23, with no revenue expected due to…
Read More »